New York City-based Paradigm, whose tech streamlines data aggregation and patient recruitment to speed up clinical trials, launches with a $203M Series A (Maureen Farrell/New York Times)
New York City-based Paradigm, whose tech streamlines data aggregation and patient recruitment to speed up clinical trials, launches with a $203M Series A — New York-based Paradigm has raised a significant amount to simplify clinical trials. Its goal is ambitious, but its challenges are many, researchers say.
from Techmeme https://ift.tt/1j4oidZ
Comments
Post a Comment